Clinical trials
Phase 2 Respiratory Insufficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 21 |
| 2021 | 4 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 8 |
| Unknown status | 8 |
| Recruiting | 7 |
| Withdrawn | 6 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NICHD Neonatal Research Network | 3 |
| Novartis Pharmaceuticals | 3 |
| Johns Hopkins University | 2 |
| University of Turin, Italy | 2 |
| Zhejiang University | 2 |
| AbbVie | 1 |
| Abraham Edgar Gracia-Ramos | 1 |
| Al-Azhar University | 1 |
| Alexandria University | 1 |
| Angion Biomedica Corp | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Insufficiency | 58 |
| COVID-19 | 19 |
| Respiratory Distress Syndrome | 15 |
| Pneumonia | 6 |
| Acute Lung Injury | 4 |
| Coronavirus Infections | 4 |
| Hypoxia | 4 |
| Pancreatitis | 4 |
| Critical Illness | 3 |
| Hypertension, Pulmonary | 3 |
Trials
Showing 76 to 58 of 58. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.